ASBP

Aspire Biopharma
ASBP

15 hedge funds and large institutions have $876K invested in Aspire Biopharma in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

84% less capital invested

Capital invested by funds: $5.36M → $876K (-$4.48M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$350K
2
+$183K
3
+$62K
4
PA
Procyon Advisors
Connecticut
+$57.4K
5
PC
Periscope Capital
Ontario, Canada
+$33.8K

Top Sellers

1
-$183K
2
-$175K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$350K
2
$183K
3
$87.4K
4
$62K
5
$57.4K
6
$33.8K
7
$21.9K
8
$17.5K
9
$16K
10
$15.7K
11
$12.2K
12
$10K
13
$9.34K
14
$82
15
$12
16
–